These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 228124)

  • 1. Effect of metyrapone and aminoglutethimide on the murine sarcoma (MuSV-M) and breast adenocarcinoma (C3HBA).
    Seifter E; Critselis AN; Levenson SM; Rettura G
    J Surg Oncol; 1979; 12(3):281-8. PubMed ID: 228124
    [No Abstract]   [Full Text] [Related]  

  • 2. Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
    Thorén M; Adamson U; Sjöberg HE
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):451-7. PubMed ID: 3898689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor growth by metyrapone and desoxycorticosterone.
    Rettura G; Sarkar D; Padawer J; Levenson SM; Seifter E
    Surg Forum; 1976; 27(62):153-4. PubMed ID: 1019837
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogenic and antineoplastic activity of a series of transformed analogs of estrone and estradiol].
    Sorokina IB; Barkova TI; Zakharychev AA; Chigir' RN; Ananchenko SN
    Izv Akad Nauk SSSR Biol; 1973; 5():664-70. PubMed ID: 4761310
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the effect of a new verucarin E analog WER I on the growth of experimental neoplasms].
    Nowak HF; Jodczyk KJ; Zimnoch L; Duda D; Piotrowska-Olczak H; Rózański A
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1980; 25():175-95. PubMed ID: 6797024
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined treatment with radioestradiol-lucanthone in mouse C3HBA mammary adenocarcinoma and with estradiol-lucanthone in an estrogen bioassay.
    Padawer J; Rettura G; Thysen B; Gatz M; Seifter E
    Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):349-57. PubMed ID: 7275712
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer properties of isoniazid & hydrazine-sulphate.
    Bhide SV
    Indian J Exp Biol; 1978 Aug; 16(8):926-8. PubMed ID: 711258
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful long-term coumadin anticoagulation of mice with prothrombin time monitoring.
    Ryan JJ; Orme SK; Wexler H; Ketcham AS
    J Surg Oncol; 1969; 1(2):115-21. PubMed ID: 5406360
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
    Mihich E; Gelzer J
    Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
    [No Abstract]   [Full Text] [Related]  

  • 13. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
    Maral R; Bourat G; Ducrot R; Fournel J; Ganter P; Julou L; Koenig F; Myon J; Pascal S; Pasquet J; Populaire P; de Ratuld Y; Werner GH
    Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
    [No Abstract]   [Full Text] [Related]  

  • 14. Theoretical basis for response to steroid suppression in major depression.
    Rothschild AJ; Schatzberg AF
    J Clin Psychopharmacol; 1992 Apr; 12(2):142-4. PubMed ID: 1573041
    [No Abstract]   [Full Text] [Related]  

  • 15. Apoptosis in murine tumors treated with chemotherapy agents.
    Meyn RE; Stephens LC; Hunter NR; Milas L
    Anticancer Drugs; 1995 Jun; 6(3):443-50. PubMed ID: 7670143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
    Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
    Bissery MC; Guénard D; Guéritte-Voegelein F; Lavelle F
    Cancer Res; 1991 Sep; 51(18):4845-52. PubMed ID: 1680023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concepts for controlling drug-resistant tumor cells.
    Schabel FM; Skipper HE; Trader MW; Laster WR; Corbett TH; Griswold DP
    Eur J Cancer (1965); 1980; Suppl 1():199-211. PubMed ID: 6947891
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of estrogen and antiestrogen therapy in rats bearing mesenchymal tumors.
    Remedi MM; Demarchi M; Hliba E; Depiante-Depaoli M
    Tumour Biol; 1999; 20(5):242-50. PubMed ID: 10436416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies.
    Aguirre G; Boiani M; Cerecetto H; Fernández M; González M; León E; Pintos C; Raymondo S; Arredondo C; Pacheco JP; Basombrío MA
    Pharmazie; 2006 Jan; 61(1):54-9. PubMed ID: 16454207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.